Management and survival of colorectal cancer in the elderly in population-based studies

European Journal of Cancer

Volumn 43, Issue 15, 2007, Pages 2279-2284

  Faivre, J ^a   Lemmens, V E P P ^b   Quipourt, V ^a   Bouvier, A M ^a  

^a Chu   (France)

^b Eindhoven Cancer Registry   (Netherlands)

Author keywords

Cancer registry; Colorectal cancer; Elderly; Survival; Treatment

Indexed keywords

FLUOROURACIL;

ADJUVANT THERAPY; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COMORBIDITY; EASTERN EUROPE; GROUPS BY AGE; HUMAN; PATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REGISTER; SURGICAL MORTALITY; WESTERN EUROPE;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EUROPE; HUMANS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 35148864588     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.08.008     Document Type: Article

References (50)

1. Parkin MD, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol VIII, IARC Scientific Publications n°155, Lyon, 2002.
2. Mitry E., Bouvier A.M., Esteve J., and Faivre J. Improvement in colorectal cancer survival: a population-based study. Eur J Cancer 4 (2005) 2297-2303
3. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38 (1982) 933-942
4. Colorectal Cancer collaborative Group. Surgery for colorectal cancer in elderly patients : a systematic review. Lancet 356 (2000) 968-974
5. Bouvier A.M., Launoy G., Lepage C., and Faivre J. Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther 22 (2005) 233-241
6. Bouhier K., Maurel J., Lefevre H., Bouin M., Arsene D., and Launoy G. Changes practices for diagnosis and treatment of colorectal cancer in Calvados : 1990-1999. Gastroenterol Clin Biol 28 (2004) 371-376
7. Faivre-Finn C., Bouvier-Benhamiche A.M., Phelip J.M., ManfrediI S., Dancourt V., and Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut 51 (2002) 60-64
8. Iversen L.H., Pedersen L., Riis A., Friis S., Laurberg S., and Sorensen H.T. Age and colorectal cancer with focus on the elderly : trends in relative survival and initial treatment from a Danish population-based study. Dis Colon Rectum 48 (2005) 1755-1763
9. Lemmens V.E.P.P., Janssen-Heijnen M.L., Verheij C.D., Houterman S., Repelaer van Driel O.J., and Coebergh J.W. Co- morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 92 (2005) 615-623
10. Arveux I., Boutron M.C., El Mrini T., et al. Colon cancer in the elderly : evidence for major improvements in health care and survival. Br J Cancer 76 (1997) 963-967
11. Masracci T.M., Hendren S., O'Connor B., and Mc Leod R.S. The impact of surgery for colorectal cancer on quality of life and functional status in the elderly. Dis Colon Rectum 49 (2006) 1878-1884
12. Gross C.P., Guo Z., Mc Avay G.J., Allore H.G., Young M., and Tinetti M.E. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 54 (2006) 1898-1904
13. Lemmens V.E.P.P., Janssen-Heijnen M.L.G., Houterman S., et al. Which comorbid conditions predict complications after surgery for colorectal cancer?. World J Surg 31 (2007) 192-199
14. Moertel C.G., Fleming T.R., Mac Donald J.S., et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New Engl J Med 322 (1990) 352-358
15. Faivre-Finn C., Bouvier A.M., Mitry E., Rassiat E., Clinard F., and Faivre J. Chemotherapy for colon cancer in a well- defined French population: is it under- or over-prescribed?. Aliment Pharmacol Ther 16 (2002) 353-359
16. Lemmens V.E.P.P., van Halteren A.H., Janssen-Heijnen M.L., Vreugdenhil G., Repelaer van Driel O.J., and Coebergh J.W. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 16 (2005) 767-772
17. Bouchardy C., Queneau P.E., Fioretta G., et al. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes : use and benefit in routine health care practice. Br J Cancer 85 (2001) 1251-1257
18. Morris M., Platell C., Fritschi L., and Iacopetta B. Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients. Br J Cancer 96 (2007) 701-707
19. Phelip J.M., Grosclaude P., Launoy G., et al. Are there regional differences in the management of colon cancer in France?. Eur J Cancer Prev 14 (2005) 31-37
20. Fietkau R., Zettl H., Klocking S., and Kundt G. Incidence, therapy and prognosis of colorectal cancer in different age groups. Strahlenther Onkol 180 (2004) 478-487
21. Potosky A.L., Harlan L.C., Kaplan R.S., Johson K.A., and Lynch C.F. Age, sex and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20 (2002) 1192-1202
22. Schrag D., Cramer L.D., Bach C.B., and Begg P.B. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. JNCI 93 (2001) 850
23. Dobie S.A., Baldwin L.M., Dominitz J.A., Matthews B., Billingskey K., and Barlow W. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst 98 (2006) 610-619
24. Sundararajan V., Grann V.R., Jacobson J.S., et al. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. Cancer J 7 (2001) 213
25. Ayanian J.Z., Zaslavsky A.M., Fuchs C.S., et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol (2003) 1293-1300
26. Neugut A.I., Matasar M., Wang X., et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol 24 (2006) 2368-2375
27. Cronin D.P., Harlan L.C., Potosky A.L., Clegg L.X., Stevens J.L., and Mooney M.M. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol 101 (2006) 2308-2318
28. Gross C.P., McAvay G.J., Guo Z., and Tinetti M.E. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer 109 (2007) 2410-2419
29. Jessup M., Stewart A., Greene F.L., and Minsky B.D. Adjuvant chemotherapy for stage III colon cancer : implications of race, ethnicity, age and differentiation. JAMA 294 (2005) 2703-2711
30. Sundararajan V., Mitra N., Jacobson J.S., Grann V.R., Meitjan D.F., and Neugut A.I. Survival associated with 5-FU-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Inter Med 136 (2002) 349-357
31. Sargent D.J., Goldberg R.M., Jacobson S.D., et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345 (2001) 1091-1097
32. Kohne C.H., Grothey A., Bokemeyer C., Barthke N., and Aapro M. Chemotherapy in elderly patients with colorectal cancer. Ann Oncol 12 (2001) 435-442
33. Yellen S.B., Cella D.F., and Leslie W.T. Age and clinical decision making in oncology patients. J Natl Cancer Inst 86 (1994) 1766-1770
34. Newcomb P.A., and Carbone P.P. Cancer treatment and age : patient perspectives. J Natl Cancer Inst 85 (1993) 1580-1584
35. Bouvier A.M., Bauvin E., Danzon A., et al. Place of multidisciplinary consulting meetings and clinical trials in the management of colorectal cancer in France in 2000. Gastroenterol Clin Biol 31 (2007) 286-291
36. Manfredi S., Bouvier A.M., Lepage C., Hatem C., Dancourt V., and Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 93 (2006) 1115-1122
37. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 34 (2001) 638-646
38. Faivre-Finn C., Benhamiche A.M., Maingon P., Janoray P., and Faivre J. Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population. Radiother Oncol 57 (2000) 137-142
39. Neugut A.I., Fleischauer A.T., Sundararajan V., et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol 20 (2002) 2643-2650
40. Martijn H., Voogd A.C., van de Poll-Franse L.V., Repelaer van Driel O.J., Rutten H.J., and Coebergh J.W. Colorectal Cancer Study Group of the Comprehensive Cancer Centre South (IZK). Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer 39 (2003) 2073-2079
41. Shahir M.A., Lemmens V.E.P.P., van de Poll-Franse L.V., Voogd A.C., Martijn H., and Janssen-Heijnen M.L.G. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer porognosis than younger patients: a population-based study. Eur J Cancer 42 (2006) 3015-3021
42. Vulto A.J., Lemmens V.E.P.P., Louwman W.J., Janssen-Heijnen M.L.G., Poortmans P.H., Lybeert M.L., et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995-2002. Cancer 15 (2006) 2734-2742
43. Mitry E., Bouvier A.M., Esteve J., and Faivre J. Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg 89 (2002) 1557-1562
44. Enblad P., Adami H.O., Bergstrom R., et al. Improved survival of patients with cancers of the colon and rectum?. J Natl Cancer Inst 80 (1988) 586-591
45. Berrino F. Survival in cancer patients in Europe : the EUROCARE-3 Study. Ann Oncol 14 suppl 5 (2003)
46. Quaglia A., Capocaccia R., Micheli A., Carrani E., Vercelli M., A wide difference in cancer survival between middle a., et al., and the EUROCARE-3 working group. Int J Cancer 15 (2007) 2196-2201
47. Bossard N., Velten M., Remontet L., et al. Survival of cancer patients in France : a population-based study from the Association of the French Cancer Registries. Eur J Cancer 43 (2007) 149-160
48. Monnet E., Faivre J., Raymond L., et al. Influence of stage at diagnosis on survival differences for rectal cancer in three European populations. Br J Cancer 81 (1999) 463-468
49. Micheli A., Coebergh J.W., Mugno E., et al. European health system and cancer care. Ann Oncol 14 suppl 5 (2003) v41-v60
50. Martijn H, Vulto JCM. Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer? Eur J Cancer [in this issue].